Inactive Instrument

Algeta ASA Share Price Other OTC

Equities

End-of-day quote Other OTC Other stock markets
- ^USD	-

2014	Actavis : Factbox - M&A frenzy transforming global pharma	RE
2014	Actavis : M&A frenzy in healthcare sector	RE

Actavis : Factbox - M&A frenzy transforming global pharma	06/05/14	RE
Actavis : M&A frenzy in healthcare sector	06/05/14	RE
Algeta ASA : UK cost agency says 'no' to Bayer prostate cancer drug Xofigo	24/03/14	RE
Algeta ASA : Bayer clinches $2.9 billion deal for Norway's Algeta	24/02/14	RE
Bayer AG : Bayer wins cancer firm Algeta with raised $2.9 billion bid	19/12/13	RE
Bayer AG : Bayer wins cancer firm Algeta with raised $2.9 billion bid	19/12/13	RE
OTSUKA CORPORATION : Bayer bids $2.4 billion for Norwegian cancer drug partner Algeta	26/11/13	RE
OTSUKA CORPORATION : Bayer bids $2.4 billion for Norwegian cancer drug partner Algeta	26/11/13	RE
Bayer AG : Bayer says does not want to provide details on Algeta offer	26/11/13	RE

Algeta ASA : Algeta to host Capital Markets Days	18/11/13	PU
Algeta ASA : CORRECTION: Algeta ASA : Algeta Results for the Third Quarter 2013	08/11/13	PU
Algeta ASA : Algeta's Financial Calendar 2014	08/11/13	PU
Algeta ASA : Algeta to Participate in Upcoming Investor Conferences	05/11/13	PU
Algeta ASA : Algeta Schedules Third Quarter 2013 Results Presentation, Webcast and Conference Call	28/10/13	PU

26/11/13

Sector

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+20.03%	126B
REGENERON PHARMACEUTICALS, INC.	+23.61%	118B
ARGENX SE	+23.26%	27.87B
BIONTECH SE	-18.07%	20.95B
GENMAB A/S	-15.13%	16.92B
BEIGENE, LTD.	-14.81%	16.18B
NEUROCRINE BIOSCIENCES, INC.	+9.78%	14.84B
WUXI APPTEC CO., LTD.	-46.10%	14.79B
SAREPTA THERAPEUTICS, INC.	+52.34%	14.08B